NVRO - Nevro Corp.
84.99 0.00 (0.00%)
After hours: 4:17PM EDT
| Previous Close | 82.31 |
| Open | 82.86 |
| Bid | 84.94 x 900 |
| Ask | 84.98 x 800 |
| Day's Range | 82.51 - 85.53 |
| 52 Week Range | 34.75 - 91.60 |
| Volume | 377,251 |
| Avg. Volume | 398,166 |
| Market Cap | 2.625B |
| Beta (3Y Monthly) | 0.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.06 |
| Earnings Date | Nov 6, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 74.11 |
- PR Newswire
Nevro to Report Third Quarter 2019 Financial Results
Company to Host Conference Call on Wednesday, November 6, 2019 at 1:30 p.m. PT / 4:30 p.m. ET REDWOOD CITY, Calif. , Oct. 10, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company ...
- Thomson Reuters StreetEvents
Edited Transcript of NVRO earnings conference call or presentation 8-Aug-19 8:30pm GMT
Q2 2019 Nevro Corp Earnings Call
- Zacks
Here's Why You Should Hold on to Nevro (NVRO) Stock for Now
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
- Zacks
Why Is Nevro (NVRO) Up 37.7% Since Last Earnings Report?
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- PR Newswire
Nevro Announces Completion of Patient Enrollment in Largest Multicenter Randomized Controlled Trial of High Frequency Spinal Cord Stimulation for Painful Diabetic Neuropathy
REDWOOD CITY, Calif. , Aug. 28, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain conditions, ...
- PR Newswire
Nevro to Present at Morgan Stanley 17th Annual Healthcare Conference
REDWOOD CITY, Calif. , Aug. 23, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, ...
- Zacks
Here's Why You Should Retain Nevro (NVRO) in Your Portfolio
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
- Simply Wall St.
Health Check: How Prudently Does Nevro (NYSE:NVRO) Use Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- Zacks
Nevro (NVRO) Catches Eye: Stock Jumps 6.3%
Nevro (NVRO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Motley FoolNevro Corp (NVRO) Q2 2019 Earnings Call Transcript
NVRO earnings call for the period ending June 30, 2019.
- Zacks
Nevro (NVRO) Q2 Loss Wider Than Expected, Revenues Down Y/Y
Nevro (NVRO) sees dismal segmental performance in Q2.
- PR Newswire
Nevro Reports Second Quarter 2019 Financial Results
REDWOOD CITY, Calif. , Aug. 8, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today ...
- Zacks
Earnings Preview: Nevro (NVRO) Q2 Earnings Expected to Decline
Nevro (NVRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
Nevro Announces Court Order Granting Preliminary Injunction Against Stimwave Technologies, Inc.
REDWOOD CITY, Calif. , July 25, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ...
- PR Newswire
Nevro to Report Second Quarter 2019 Financial Results
Company to Host Conference Call on Thursday, August 8, 2019 at 1:30 p.m. PT / 4:30 p.m. ET REDWOOD CITY, Calif. , July 15, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company ...
- Zacks
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, severe rivalry is a lingering woe.
- PR Newswire
Nevro Announces Executive Appointments
Names Niamh Pellegrini as Chief Commercial Officer and Lori Ciano as Chief Human Resources Officer REDWOOD CITY, Calif. , June 25, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device ...
- Simply Wall St.
Nevro Corp. (NYSE:NVRO) Insiders Increased Their Holdings
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
- Insider Monkey
Is Nevro Corp (NVRO) A Good Stock To Buy ?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged during the first quarter. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 40% and 25% respectively. Our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted […]
- Thomson Reuters StreetEvents
Edited Transcript of NVRO earnings conference call or presentation 9-May-19 8:30pm GMT
Q1 2019 Nevro Corp Earnings Call
- PR Newswire
Nevro to Present at BMO 2019 Prescriptions for Success Healthcare Conference
REDWOOD CITY, Calif. , June 11, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, ...
- Markit
See what the IHS Markit Score report has to say about Nevro Corp.
Nevro Corp NYSE:NVROView full report here! Summary * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for NVRO with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold NVRO had net inflows of $754 million over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks
Nevro (NVRO) Down 3.6% Since Last Earnings Report: Can It Rebound?
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
